
About Acolyte Pharmacare Private Limited
Data last updated:
Acolyte Pharmacare Private Limited is a private limited company based in Mehsana, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24299GJ2020PTC112503. Its GSTIN is 24AATCA2657D1ZO (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hardikkumar Nareshbhai Patel and Ravi Natvarlal Patel.
Its last annual general meeting (AGM) was held on 13 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 25 Fortune Floreon C – Link Road Radhanpur Road, Mehsana, Gujarat, India – 384002.
As per the financials filed for FY 2025, the company reported a revenue of ₹84.52 Lakh, a decline of 37% compared to the previous year. For the same year it recorded a net profit of ₹19,180 (net margin 0.2%) and EBITDA of ₹4.43 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years.
For more details, the company can be reached via its website acolytepharma.business.site.
Company details
Contact details
Acolyte Pharmacare Private Limited's registered office is in Mehsana, Gujarat. Its website is acolytepharma.business.site. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS – 25 Fortune Floreon C – Link Road Radhanpur Road, Mehsana, Gujarat, India – 384002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Acolyte Pharmacare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Acolyte Pharmacare is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Acolyte Pharmacare Private Limited, buy the company report.
Financials of Acolyte Pharmacare Private Limited
FY 2025 filings availableAcolyte Pharmacare Private Limited reported revenue of ₹84.52 Lakh (down 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 37% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 28%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.43 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19,180 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Acolyte Pharmacare Private Limited, buy the company report.
Board of directors of Acolyte Pharmacare Private Limited
Acolyte Pharmacare has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hardikkumar Nareshbhai Patel | Director | 04 Feb 2020 | 6 Years 9 Months | Current |
| Ravi Natvarlal Patel | Director | 04 Feb 2020 | 6 Years 9 Months | Current |
Peer comparison
Acolyte Pharmacare Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VSR Trading Private Limited | ₹84.57 Lakh (FY 2024) | -30.0% | Hyderabad, Telangana, India | |||
| Beucos Healthcare Private Limited | ₹84.55 Lakh (FY 2024) | -26.0% | Chennai, Tamil Nadu, India | |||
| Ajaya Kumas Private Limited | ₹84.55 Lakh (FY 2025) | 119.0% | Delhi, India | |||
| Pashupati Alcobev Private Limited | ₹84.53 Lakh (FY 2024) | -30.0% | New Delhi, Delhi, India | |||
| Amokha Drugs Private Limited | ₹84.53 Lakh (FY 2025) | 2.0% | Kochi, Kerala, India | |||
| Acolyte Pharmacare Private Limitedthis company | ₹84.52 Lakh (FY 2025) | ₹19,180 | 0.2% | -37.0% | Mehsana, Gujarat, India | |
| Lotus Furnishing Private Limited | ₹84.51 Lakh (FY 2025) | 89.0% | Delhi, India | |||
| Technovatex Private Limited | ₹84.5 Lakh (FY 2024) | -53.0% | Hyderabad, Telangana, India | |||
| Maxx Safety Private Limited. | ₹84.5 Lakh (FY 2025) | Gurgaon, Haryana, India | ||||
| Crescent Diamonds Exim Private Limited | ₹84.5 Lakh (FY 2025) | -99.0% | Surat, Gujarat, India | |||
| Dweller Private Limited | ₹84.49 Lakh (FY 2024) | 1.0% | Guwahati, Assam, India |
To see the full peer comparison of Acolyte Pharmacare Private Limited, buy the company report.
Auditor
Acolyte Pharmacare Private Limited is audited by ASHVIN K YAGNIK & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHVIN K YAGNIK & CO | FY 2022 | 100710W |
Shareholding
The shareholding of Acolyte Pharmacare Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Acolyte Pharmacare Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Acolyte Pharmacare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Acolyte Pharmacare Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Acolyte Pharmacare has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AATCA2657D1ZO | Gujarat | Active | 20 Oct 2020 |
To see the full GST registrations and return filing status of Acolyte Pharmacare Private Limited, buy the company report.
Recent activity
Acolyte Pharmacare Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Hardikkumar Nareshbhai Patel was appointed as Director on 04 Feb 2020.
Frequently asked questions
Acolyte Pharmacare is an active private limited company based in Mehsana, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2020 (6+ years old) and is registered under CIN U24299GJ2020PTC112503.
Acolyte Pharmacare has 2 current directors:
- Hardikkumar Nareshbhai Patel - Director
- Ravi Natvarlal Patel - Director
The latest financial statements of Acolyte Pharmacare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 13 August 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Acolyte Pharmacare is 24AATCA2657D1ZO, registered in Gujarat.
The CIN (Corporate Identification Number) of Acolyte Pharmacare is U24299GJ2020PTC112503. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acolyte Pharmacare was incorporated on 04 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Acolyte Pharmacare by revenue are VSR Trading Private Limited, Beucos Healthcare Private Limited, Ajaya Kumas Private Limited, Pashupati Alcobev Private Limited, Amokha Drugs Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Hardikkumar Nareshbhai Patel was appointed as Director on 04 Feb 2020. Ravi Natvarlal Patel was appointed as Director on 04 Feb 2020.
Acolyte Pharmacare can be reached through the website acolytepharma.business.site. Its registered office is in Mehsana, Gujarat, India.
The registered office of Acolyte Pharmacare is at S – 25 Fortune Floreon C – Link Road Radhanpur Road, Mehsana, Gujarat, India – 384002.
Acolyte Pharmacare operates in the pharma industry, in the drug formulation and development segment.

